Disagree
Home GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)
Avodart 0.5
Avodart 0.5 - GlaxoSmithKline (GSK)

Avodart 0.5 - GlaxoSmithKline (GSK)

Brand:
Category:
Substance:
Dosage:
500 mcg/tab
Package:
30 tablets
Price:
$59.00 - $59.00
See options
Product Overview

Dutasteride is a dual 5-alpha reductase inhibitor, meaning it suppresses both type-1 and type-2 enzymes that convert testosterone into dihydrotestosterone (DHT). DHT is linked to androgenic effects like hair loss and prostate growth, making Dutasteride effective in treating conditions such as benign prostatic hyperplasia (BPH). Unlike finasteride, which selectively inhibits only type-2 5-alpha reductase, Dutasteride’s broad inhibition achieves more comprehensive suppression of DHT levels. This reduction in DHT not only alleviates BPH symptoms but may also help prevent hair loss and other androgenic effects, benefiting users looking to minimize these concerns​.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Avodart 0.5 by GlaxoSmithKline (GSK), consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What is Dutasteride?
Dutasteride is a dual 5-alpha reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT) by targeting both type-1 and type-2 enzymes.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What conditions is Dutasteride used to treat?
It is primarily used to treat benign prostatic hyperplasia (BPH) and may also help reduce male pattern hair loss by lowering DHT levels.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How does Dutasteride differ from Finasteride?
Unlike Finasteride, which only inhibits type-2 5-alpha reductase, Dutasteride inhibits both type-1 and type-2, resulting in a more comprehensive reduction in DHT levels.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.